Myelodysplastic Syndrome-Refractory Anemia With Excess Blasts
1 clinical trials · Condition
◉ Watch Myelodysplastic Syndrome-Refractory Anemia With Excess Blasts
| Record | Firm | Date |
|---|---|---|
| Vaccination With GM-K562 Cells in Patients With Advanced Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) After Allogeneic Hematopoetic Stem Cell Transplantation (NCT00809250) | Dana-Farber Cancer Institute | 2008-11-01 |
Track Myelodysplastic Syndrome-Refractory Anemia With Excess Blasts automatically
Every clearance here is in the API, with alerts when new ones post.